You have 9 free searches left this month | for more free features.

Taeniasis

Showing 1 - 25 of 30

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Treated Neurocysticercosis and Long-Term Outcomes

Recruiting
  • Cysticercosis
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Subarachnoid Neurocysticercosis Trial (Albendazole)

    Withdrawn
    • Subarachnoid Neurocysticercosis
    • (no location specified)
    Apr 4, 2022

    Two Cases of Pulmonary Cysticercosis Manifesting as Pleural

    Completed
    • Cysticercosis
      • (no location specified)
      Aug 24, 2021

      Neurocysticercosis Trial in Lima (Albendazole and praziquantel, Albendazole and praziquantel )

      Recruiting
      • Neurocysticercosis
      • Albendazole and praziquantel
      • Albendazole and praziquantel placebo
      • Lima, Peru
      • +1 more
      Oct 20, 2021

      Taenia Solium Infection Trial in Katete (Mass drug administration, praziquantel 10mg/kg, Health education)

      Recruiting
      • Taenia Solium Infection
      • Mass drug administration, praziquantel 10mg/kg
      • Health education
      • Katete, Eastern Province, Zambia
        Nyembe and Mtandaza Rural Health Centre
      Feb 26, 2021

      Neurocysticercosis, Tropical Disease, Tenia Solium Infection Trial

      Not yet recruiting
      • Neurocysticercosis
      • +2 more
        • (no location specified)
        Jan 9, 2021

        Neurocysticercosis Trial in Iowa City (Oxfendazole, Placebo)

        Completed
        • Neurocysticercosis
        • Iowa City, Iowa
          University of Iowa - Vaccine Research and Education Unit
        Oct 29, 2020

        HIV, Tuberculosis, Cysticercosis Trial in Dar es Salaam, Iringa, Morogoro (Digital health promotion intervention)

        Completed
        • HIV Infections
        • +3 more
        • Digital health promotion intervention
        • Dar es Salaam, Dar, Tanzania
        • +5 more
        Nov 3, 2020

        Neurocysticercosis, Healthy Trial run by the NIMH ([C-11]PBR28)

        Completed
        • Neurocysticercosis
        • Healthy
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        Dec 11, 2019

        Environmental Factors Associated With Transmission of T. Solium

        Unknown status
        • Neurocysticercosis
        • Taeniosis
          • Lusaka, Zambia
            University of Zambia
          Mar 12, 2019

          Patients With Active Neurocysticercosis in Eastern Africa

          Unknown status
          • Neurocysticercosis
            • (no location specified)
            Feb 28, 2019

            Subarachnoid Cysticercosis Trial in Worldwide (Albendazole)

            Withdrawn
            • Subarachnoid Cysticercosis
            • Riberao Preto, Brazil
            • +3 more
            Jan 28, 2019

            The Burden ofCysticercosis Among People Living With HIV in Rural

            Unknown status
            • Neurocysticercosis
            • HIV/AIDS
            • Diagnosis of (Neuro)cysticercosis
            • Dar Es Salaam, Tanzania
              National Institute of Medical Research
            Feb 28, 2019

            Intestinal Parasites in Inhabitants of Kuyavian-Pomeranian

            Completed
            • Intestinal Disease, Parasitic
            • Chronic Disease
            • Tests for diagnosis of intestinal parasitic diseases
            • Bydgoszcz, Kujawsko-Pomorskie, Poland
              The Chair of Medical Biology, Collegium Medicum of Nicolaus Cope
            Mar 25, 2020

            Neurocysticercosis, Healthy Trial run by the NIMH ([F-18]FBR)

            Completed
            • Neurocysticercosis
            • Healthy
            • Bethesda, Maryland
              National Institutes of Health Clinical Center, 9000 Rockville Pi
            Jul 3, 2018

            People Presenting With Neurocysticercosis in North America

            Terminated
            • Neurocysticercosis
              • San Francisco, California
              • +3 more
              Apr 4, 2018

              Cysticercosis Trial in Bobo Dioulasso (Educational package)

              Completed
              • Cysticercosis
              • Educational package
              • Bobo Dioulasso, Burkina Faso
                AFRICSanté
              Mar 30, 2018

              Brain Tissue Swelling and Seizure Activity in Inactive

              Completed
              • Cysticercosis
              • +2 more
                • Bethesda, Maryland
                • +1 more
                Jun 30, 2017

                Neurocysticercosis Trial in Lima (Albendazole, Dexamethasone, Omeprazole)

                Completed
                • Neurocysticercosis
                • Lima, Peru
                  Instituto Especializado en Ciencias Neurologicas
                Feb 2, 2017

                Visceral Leishmaniosis, HIV-infection/Aids Trial in Abdurafi, Humera, Gondar (Pentamidine)

                Completed
                • Visceral Leishmaniosis
                • HIV-infection/Aids
                • Abdurafi, Amhara, Ethiopia
                • +2 more
                Oct 5, 2018

                Tenia Solium Infection Trial (oxfendazole, )

                Withdrawn
                • Tenia Solium Infection
                • (no location specified)
                Aug 29, 2016

                Anemia Trial in Worldwide (Roxadustat, Placebo)

                Completed
                • Anemia
                • Birmingham, Alabama
                • +359 more
                Nov 27, 2019

                Malaria Trial in Worldwide (Malaria Vaccine 257049, Meningococcal C Conjugate Vaccine, Cell-culture rabies vaccine)

                Completed
                • Malaria
                • Malaria Vaccine 257049
                • +4 more
                • Ouagadougou, Burkina Faso
                • +9 more
                Sep 19, 2019

                Neurocysticercosis Trial in New Delhi (7 days of albendazole 15 mg/kg/day, 28 days of albendazole 15 mg/kg/day)

                Completed
                • Neurocysticercosis
                • 7 days of albendazole 15 mg/kg/day
                • 28 days of albendazole 15 mg/kg/day
                • New Delhi, Delhi, India
                  sheffali Gulati
                Dec 31, 2015

                Epilepsy, Cysticercosis Trial (albendazole, dexamethasone, phenytoin)

                Completed
                • Epilepsy
                • Cysticercosis
                • (no location specified)
                Mar 24, 2015